Identification of Candidate Parkinson Disease Genes by Integrating Genome-Wide Association Study, Expression, and Epigenetic Data Sets
- PMID: 33523105
- PMCID: PMC7851759
- DOI: 10.1001/jamaneurol.2020.5257
Identification of Candidate Parkinson Disease Genes by Integrating Genome-Wide Association Study, Expression, and Epigenetic Data Sets
Abstract
Importance: Substantial genome-wide association study (GWAS) work in Parkinson disease (PD) has led to the discovery of an increasing number of loci shown reliably to be associated with increased risk of disease. Improved understanding of the underlying genes and mechanisms at these loci will be key to understanding the pathogenesis of PD.
Objective: To investigate what genes and genomic processes underlie the risk of sporadic PD.
Design and setting: This genetic association study used the bioinformatic tools Coloc and transcriptome-wide association study (TWAS) to integrate PD case-control GWAS data published in 2017 with expression data (from Braineac, the Genotype-Tissue Expression [GTEx], and CommonMind) and methylation data (derived from UK Parkinson brain samples) to uncover putative gene expression and splicing mechanisms associated with PD GWAS signals. Candidate genes were further characterized using cell-type specificity, weighted gene coexpression networks, and weighted protein-protein interaction networks.
Main outcomes and measures: It was hypothesized a priori that some genes underlying PD loci would alter PD risk through changes to expression, splicing, or methylation. Candidate genes are presented whose change in expression, splicing, or methylation are associated with risk of PD as well as the functional pathways and cell types in which these genes have an important role.
Results: Gene-level analysis of expression revealed 5 genes (WDR6 [OMIM 606031], CD38 [OMIM 107270], GPNMB [OMIM 604368], RAB29 [OMIM 603949], and TMEM163 [OMIM 618978]) that replicated using both Coloc and TWAS analyses in both the GTEx and Braineac expression data sets. A further 6 genes (ZRANB3 [OMIM 615655], PCGF3 [OMIM 617543], NEK1 [OMIM 604588], NUPL2 [NCBI 11097], GALC [OMIM 606890], and CTSB [OMIM 116810]) showed evidence of disease-associated splicing effects. Cell-type specificity analysis revealed that gene expression was overall more prevalent in glial cell types compared with neurons. The weighted gene coexpression performed on the GTEx data set showed that NUPL2 is a key gene in 3 modules implicated in catabolic processes associated with protein ubiquitination and in the ubiquitin-dependent protein catabolic process in the nucleus accumbens, caudate, and putamen. TMEM163 and ZRANB3 were both important in modules in the frontal cortex and caudate, respectively, indicating regulation of signaling and cell communication. Protein interactor analysis and simulations using random networks demonstrated that the candidate genes interact significantly more with known mendelian PD and parkinsonism proteins than would be expected by chance.
Conclusions and relevance: Together, these results suggest that several candidate genes and pathways are associated with the findings observed in PD GWAS studies.
Conflict of interest statement
Figures


Similar articles
-
Increased brain expression of GPNMB is associated with genome wide significant risk for Parkinson's disease on chromosome 7p15.3.Neurogenetics. 2017 Jul;18(3):121-133. doi: 10.1007/s10048-017-0514-8. Epub 2017 Apr 8. Neurogenetics. 2017. PMID: 28391543 Free PMC article.
-
Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies.Lancet Neurol. 2019 Dec;18(12):1091-1102. doi: 10.1016/S1474-4422(19)30320-5. Lancet Neurol. 2019. PMID: 31701892 Free PMC article.
-
Joint analysis of proteome, transcriptome, and multi-trait analysis to identify novel Parkinson's disease risk genes.Aging (Albany NY). 2024 Jan 17;16(2):1555-1580. doi: 10.18632/aging.205444. Epub 2024 Jan 17. Aging (Albany NY). 2024. PMID: 38240717 Free PMC article.
-
Candidate genes for Parkinson disease: Lessons from pathogenesis.Clin Chim Acta. 2015 Sep 20;449:68-76. doi: 10.1016/j.cca.2015.04.042. Epub 2015 Jun 3. Clin Chim Acta. 2015. PMID: 26048192 Review.
-
Epigenetic regulation in Parkinson's disease.Acta Neuropathol. 2016 Oct;132(4):515-30. doi: 10.1007/s00401-016-1590-9. Epub 2016 Jun 29. Acta Neuropathol. 2016. PMID: 27358065 Free PMC article. Review.
Cited by
-
A comprehensive survey on computational learning methods for analysis of gene expression data.Front Mol Biosci. 2022 Nov 7;9:907150. doi: 10.3389/fmolb.2022.907150. eCollection 2022. Front Mol Biosci. 2022. PMID: 36458095 Free PMC article. Review.
-
Parkinson's disease and schizophrenia interactomes contain temporally distinct gene clusters underlying comorbid mechanisms and unique disease processes.Schizophrenia (Heidelb). 2024 Feb 27;10(1):26. doi: 10.1038/s41537-024-00439-3. Schizophrenia (Heidelb). 2024. PMID: 38413605 Free PMC article.
-
A Genome-Wide Association Study of 2304 Extreme Longevity Cases Identifies Novel Longevity Variants.Int J Mol Sci. 2022 Dec 21;24(1):116. doi: 10.3390/ijms24010116. Int J Mol Sci. 2022. PMID: 36613555 Free PMC article.
-
Targeting of Lysosomal Pathway Genes for Parkinson's Disease Modification: Insights From Cellular and Animal Models.Front Neurol. 2021 Jun 14;12:681369. doi: 10.3389/fneur.2021.681369. eCollection 2021. Front Neurol. 2021. PMID: 34194386 Free PMC article. Review.
-
Genetic variation and pesticide exposure influence blood DNA methylation signatures in females with early-stage Parkinson's disease.NPJ Parkinsons Dis. 2024 May 7;10(1):98. doi: 10.1038/s41531-024-00704-3. NPJ Parkinsons Dis. 2024. PMID: 38714693 Free PMC article.
References
-
- Chang D, Nalls MA, Hallgrímsdóttir IB, et al. ; International Parkinson’s Disease Genomics Consortium; 23andMe Research Team . A meta-analysis of genome-wide association studies identifies 17 new Parkinson’s disease risk loci. Nat Genet. 2017;49(10):1511-1516. doi:10.1038/ng.3955 - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
- K-1602/PUK_/Parkinson's UK/United Kingdom
- J-0804/PUK_/Parkinson's UK/United Kingdom
- MR/L501542/1/MRC_/Medical Research Council/United Kingdom
- G0802462/MRC_/Medical Research Council/United Kingdom
- G0701075/MRC_/Medical Research Council/United Kingdom
- G1100643/MRC_/Medical Research Council/United Kingdom
- MR/L010933/1/MRC_/Medical Research Council/United Kingdom
- G-1502/PUK_/Parkinson's UK/United Kingdom
- MR/N026004/1/MRC_/Medical Research Council/United Kingdom
- MR/K01417X/1/MRC_/Medical Research Council/United Kingdom
- G-0907/PUK_/Parkinson's UK/United Kingdom
- MR/N008324/1/MRC_/Medical Research Council/United Kingdom
- G0901254/MRC_/Medical Research Council/United Kingdom
- G-1309/PUK_/Parkinson's UK/United Kingdom
- G0700943/MRC_/Medical Research Council/United Kingdom
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous